Cymabay Therapeutics Overview

Cymabay Therapeutics Gross Profit

Gross Profit analysis for CBAY.

Quarterly Gross Profit

$1000.00

↓ 100.54% YoY

As of Dec 31, 2023

Annual Gross Profit (TTM)

$30.39M

↓ 5717.74% YoY

Trailing 12 months ending Dec 31, 2023

Average Gross Profit (Comparison Companies)

Gross Profit History

Gross Profit Comparison

Annual Gross Profit Growth Rate (%)

Annual Gross Profit Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin